[HTML][HTML] Phosphorylated tau in Alzheimer's disease and other tauopathies
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …
[HTML][HTML] Insulin and insulin resistance in Alzheimer's disease
A Sędzikowska, L Szablewski - International journal of molecular sciences, 2021 - mdpi.com
Insulin plays a range of roles as an anabolic hormone in peripheral tissues. It regulates
glucose metabolism, stimulates glucose transport into cells and suppresses hepatic glucose …
glucose metabolism, stimulates glucose transport into cells and suppresses hepatic glucose …
Cryo-EM structures of tau filaments
SHW Scheres, W Zhang, B Falcon… - Current Opinion in …, 2020 - Elsevier
Highlights•Cryo-EM may be used to determine atomic structures of amyloid filaments
extracted from human brain tissue.•Unique protofilament folds characterise tau filaments …
extracted from human brain tissue.•Unique protofilament folds characterise tau filaments …
[HTML][HTML] The neuroprotective potentiality of flavonoids on Alzheimer's disease
Alzheimer's disease (AD), due to its spread, has become a global health priority, and is
characterized by senile dementia and progressive disability. The main cause of AD and …
characterized by senile dementia and progressive disability. The main cause of AD and …
[HTML][HTML] Friend or foe—Post-translational modifications as regulators of phase separation and RNP granule dynamics
M Hofweber, D Dormann - Journal of Biological Chemistry, 2019 - ASBMB
Ribonucleoprotein (RNP) granules are membrane-less organelles consisting of RNA-
binding proteins (RBPs) and RNA. RNA granules form through liquid–liquid phase …
binding proteins (RBPs) and RNA. RNA granules form through liquid–liquid phase …
[HTML][HTML] Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common
type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD …
type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD …
[HTML][HTML] Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient …
Background Cerebrospinal fluid biomarker profiles characterized by decreased amyloid-
beta peptide levels and increased total and phosphorylated tau levels at threonine 181 …
beta peptide levels and increased total and phosphorylated tau levels at threonine 181 …
Tau imaging: early progress and future directions
VL Villemagne, MT Fodero-Tavoletti… - The Lancet …, 2015 - thelancet.com
Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation
in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies …
in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies …
[HTML][HTML] GSK-3β, a pivotal kinase in Alzheimer disease
M Llorens-Marítin, J Jurado, F Hernández… - Frontiers in molecular …, 2014 - frontiersin.org
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
Biochemistry and cell biology of tau protein in neurofibrillary degeneration
EM Mandelkow, E Mandelkow - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD),
the neurofibrillary tangles, and is therefore of major interest as an indicator of disease …
the neurofibrillary tangles, and is therefore of major interest as an indicator of disease …